Floatz logo

Therapeutic Asset Ratings

13,155 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Azacitidine
Extranodal Nasal NK/T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineP2B (58)
Azacitidine
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
Alliance for Clinical Trials in OncologyP2B (58)
Azacitidine
Myelodysplastic/Myeloproliferative Neoplasm
Karolinska University HospitalP2B (58)
Azacytidine
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Ruijin HospitalP2B (58)
Bbt-877
Idiopathic Pulmonary Fibrosis
Bridge Biotherapeutics, Inc.P2B (58)
Bcma Car-T Cells
Plasma Cell Myeloma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2B (58)
Belinostat
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P2B (58)
Belinostat
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P2B (58)
Bendamustine
Breast Cancer
University of ZurichP2B (58)
Bendamustine
Primary Mediastinal Large B-Cell Lymphoma
Miltenyi Biomedicine GmbHP2B (58)
Bendamustine
Prostate Carcinoma
Fred Hutchinson Cancer CenterP2B (58)
Bicalutamide
Breast Carcinoma
OHSU Knight Cancer InstituteP2B (58)
Binimetinib
Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)P2B (58)
Binimetinib
Colorectal Carcinoma
Roswell Park Cancer InstituteP2B (58)
Binimetinib
Exocrine Pancreatic Carcinoma
Roswell Park Cancer InstituteP2B (58)
Binimetinib
Lung Carcinoma
University of California, San FranciscoP2B (58)
Binimetinib
Rectal Carcinoma
University of California, San FranciscoP2B (58)
Binimetinib
Skin Carcinoma
H. Lee Moffitt Cancer Center and Research InstituteP2B (58)
Binimetinib
Malignant Pancreatic Neoplasm
National Cancer Institute (NCI)P2B (58)
Blinatumomab
Chronic Myeloid Leukemia
M.D. Anderson Cancer CenterP2B (58)
Blinatumomab
Acute Myeloid Leukemia
Ascentage Pharma Group Inc.P2B (58)
Bmn 351
Duchenne Muscular Dystrophy
BioMarin PharmaceuticalP2B (58)
bnt116
Non-Small Cell Lung Carcinoma
Regeneron PharmaceuticalsP2B (58)
Botensilimab
Malignant Pancreatic Neoplasm
Nelum CorpP2B (58)
Brigatinib
ALK-Positive Anaplastic Large Cell Lymphoma
Princess Maxima Center for Pediatric OncologyP2B (58)
Showing 2501 to 2525 of 13,155 assets
PreviousPage 101 of 527Next